Ameloblastoma screening: Difference between revisions
Jump to navigation
Jump to search
(Category) |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Ameloblastoma}} | {{Ameloblastoma}} | ||
{{CMG}}{{AE}}{{ | {{CMG}} ; {{AE}} {{VKG}} | ||
==Overview== | ==Overview== | ||
According to the United States Preventive Services Task Force, screening for ameloblastoma is not recommended. | According to the United States Preventive Services Task Force, screening for [[ameloblastoma]] is not recommended. | ||
==Screening== | ==Screening== | ||
Current medical research has not established a way of preventing ameloblastoma | Current medical research has not established a way of preventing [[ameloblastoma]]. | ||
==References== | ==References== | ||
Revision as of 17:00, 4 October 2018
Ameloblastoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Ameloblastoma screening On the Web |
American Roentgen Ray Society Images of Ameloblastoma screening |
Risk calculators and risk factors for Ameloblastoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
According to the United States Preventive Services Task Force, screening for ameloblastoma is not recommended.
Screening
Current medical research has not established a way of preventing ameloblastoma.